MicrobiologybioRxiv
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice
J.-H. Tian, N. Patel, R. Haupt…·G. Smith
This study evaluates the immunogenicity and protective efficacy of the NVX-CoV2373 SARS-CoV-2 vaccine in baboons and mice, showing strong immune responses and protection without enhanced disease.
DOI 10.1038/s41467-020-20653-8